HealthZydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for UsnoflastNewsmantraJanuary 20, 2025 by NewsmantraJanuary 20, 20250 Zydus Lifesciences receives approval from USFDA to conduct Phase II(b) clinical trial for Usnoflast, a...
HealthAlembic Pharmaceuticals Limited announces USFDA Final Approval for Divalproex Sodium Delayed-Release Capsules USP, 125 mgNewsmantraDecember 20, 2024 by NewsmantraDecember 20, 20240 20th December, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) announced that it has received Final Approval from the...
Corporate Press ReleaseSuccessful completion of USFDA inspection at Alembic Pharmaceuticals Limited’ Oncology (Injectable and Oral Solid) Formulation Facility (F-2) at Panelav.NewsmantraOctober 9, 2024 by NewsmantraOctober 9, 20240 9th October, 2024, Bengaluru: Alembic Pharmaceuticals today announced that it has successfully completed the United States Food...
HealthAlembic Pharmaceuticals announces USFDA Final Approval for Lamotrigine Extended-Release Tablets USP, 200 mg, 250 mg, and 300 mg.NewsmantraOctober 4, 2024 by NewsmantraOctober 4, 20240 3rd October 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
HealthStrides receives USFDA approval for Fluoxetine Tabs 60 mg; Expanding the Product’s Availability Across StrengthsNewsmantraSeptember 17, 2024 by NewsmantraSeptember 17, 20240 Strides receives USFDA approval for Fluoxetine Tabs 60 mg; Expanding the Product’s Availability Across Strengths...
LucknowAlembic Pharmaceuticals announces USFDA Final Approval for Albendazole Tablets USP, 200 mg.NewsmantraSeptember 6, 2024September 6, 2024 by NewsmantraSeptember 6, 2024September 6, 20240 5th September, 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval...
HealthAlembic Pharmaceuticals announces USFDA Final Approval for Betamethasone Valerate Foam, 0.12%NewsmantraAugust 27, 2024August 27, 2024 by NewsmantraAugust 27, 2024August 27, 20240 Alembic Pharmaceuticals announces USFDA Final Approval for Betamethasone Valerate Foam, 0.12%...
HealthAlembic Pharmaceuticals announces USFDA Final Approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and 25 mgNewsmantraAugust 7, 2024August 7, 2024 by NewsmantraAugust 7, 2024August 7, 20240 Alembic Pharmaceuticals announces USFDA Final Approval for Acitretin Capsules USP, 10 mg, 17.5 mg, and...
Corporate Press ReleaseAlembic Pharmaceuticals announces USFDA Final Approval for Fluphenazine Hydrochloride Tablets USP, 1 mg, 2.5 mg, 5 mg, and 10 mg.NewsmantraJuly 24, 2024 by NewsmantraJuly 24, 20240 24th July 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received final approval from...
HealthAlembic Pharmaceuticals announces USFDA Tentative Approval for Ivosidenib Tablets 250 mgNewsmantraJuly 5, 2024 by NewsmantraJuly 5, 20240 4 July 2024, Bengaluru: Alembic Pharmaceuticals Limited (Alembic) today announced that it has received tentative approval from...